Prot # SD-809-C-18:A Randomized, Double-Blind, Placebo -Controlled Study of SD-809(Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia

Project: Research project

Project Details

StatusFinished
Effective start/end date10/7/14 → 10/7/17

Funding

  • INNO Clinical Outcomes, LLC (SD-809-C-18:A // SD-809-C-18:A)
  • Auspex Pharmaceuticals, Inc. (SD-809-C-18:A // SD-809-C-18:A)